CosmeRNA Insights

Clinical & Research
Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia – Scientific Reports (2022)

Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia – Scientific Reports (2022)

A peer-reviewed research article published in Scientific Reports (Nature Portfolio, 2022) explored the use of an RNA-based topical approach targeting the androgen receptor in individuals affected by androgenetic alopecia.

Read moreabout Weekly treatment with SAMiRNA targeting the androgen receptor ameliorates androgenetic alopecia – Scientific Reports (2022)